Keeping time with Parkinson’s Research – The TemPo Studies
If you or a loved one have been diagnosed with Parkinson’s Disease, you or your loved one may be interested in participating in one of the TemPo Studies. They are a suite of three clinical research studies evaluating an oral investigational drug (tavapadon) to see if it may help improve Parkinson’s Disease symptoms that impact movement and daily activities.
You may be eligible to participate if you meet the following eligibility criteria:
• Have been diagnosed with Parkinson’s Disease
• 40 to 80 years of age
• Have never received Deep Brain Stimulation treatment
All eligible study participants will receive at no cost:
• Study-related consultation and care
• Study visits, tests, assessments, and procedures
• Study drugs (investigational drug or placebo)
This study takes place at the Princess Alexandra Hospital in Woolloongabba, Brisbane. To participate you need to be locally based in order to travel to and from the PA Hospital. Travel reimbursements are available.
This study runs for 27 weeks approximately, and you would be required to attend the PA Hospital every 3-4 weeks for about an hour each visit.
To learn more, please contact the Clinical Trials Coordinator Annette Denny on 0436 447 386.